Mega Medi Impex Private Limited Pharmaceutical Import Profile — Nepal (DGFT 2022–2026)

Name: Mega Medi Impex Private Limited Pharmaceutical Import Records from India — 2 Products, $28.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Mega Medi Impex Private Limited — Pharmaceutical Importer Profile (2026) | 2 Products, $28.7K Trade | TransData Nexus

Mega Medi Impex Private Limited

Pharmaceutical Importer · Nepal · Ayurvedic & Herbal Products Focus · $28.7K Total Trade · DGFT Verified

Mega Medi Impex Private Limited is a pharmaceutical importer based in Nepal with a total trade value of $28.7K across 2 products in 1 therapeutic categories. Based on 60 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Mega Medi Impex Private Limited sources from 1 verified Indian supplier, with Shree Dhootapapeshwar Limited accounting for 100.0% of imports.

Mega Medi Impex Private Limited — Import Portfolio & Supplier Network

Mega Medi Impex Private Limited import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Mega Medi Impex Private Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Shree Dhootapapeshwar Limited	$62.8K	113	100.0%

Mega Medi Impex Private Limited sources from 1 verified Indian supplier across 87 distinct formulations. The sourcing is highly concentrated — Shree Dhootapapeshwar Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Amlapitta mishran-450ML	$8.5K	3
Swamala- 1 kg batch no db0923092 exp	$3.1K	1
Swamala-1kg	$2.9K	1
Mahayograj guggul-60	$2.7K	2
Amlapitta mishran-450 ML	$2.6K	4
A-flu-o-cil forte-10	$2.1K	2
Amlapitta mishran-450 ML batch no dp0123056 exp dt	$2.1K	1
Arogyavardhini blister 30	$1.9K	2
Mouktik pishiti-1GM	$1.8K	2
Chandraprabha gutika-blister-30	$1.7K	1
Gandhak rasayan-blister-30	$1.7K	4
Shilapravang special -30 t - nepal batchno ds022211 exp dt	$1.5K	1
Sheeta prabha-60	$1.3K	2
Gokshuradi guggul 60	$1.3K	2
Brt.wat chintamani-10	$1.2K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Bhasma	Ayurvedic & Herbal Products	$23.4K	49	3.6%	6
2	Gutika	Ayurvedic & Herbal Products	$5.3K	11	2.2%	12

Mega Medi Impex Private Limited imports 2 pharmaceutical products across 1 categories into Nepal totaling $28.7K.

Mega Medi Impex Private Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Mega Medi Impex Private Limited is a pharmaceutical importer based in Nepal, specializing in the procurement of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company operates as a primary wholesaler, sourcing products from Indian manufacturers to meet the demands of the Nepalese market. While specific details about its headquarters and parent company are not publicly disclosed, Mega Medi Impex plays a significant role in the distribution of Ayurvedic and herbal products within Nepal.

2Distribution Network

The company maintains a centralized warehouse in Birgunj, Nepal, strategically located to facilitate efficient distribution across the country. This location enables Mega Medi Impex to serve a wide geographic area, ensuring timely delivery of pharmaceutical products to various regions within Nepal. The logistics capabilities include temperature-controlled storage facilities to preserve the efficacy of the imported medicines.

3Industry Role

Mega Medi Impex Private Limited functions as a primary wholesaler in Nepal's pharmaceutical supply chain. By importing finished pharmaceutical formulations from India, the company bridges the gap between international manufacturers and local healthcare providers, ensuring the availability of essential medicines in the Nepalese market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Mega Medi Impex Private Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy is highly concentrated, relying exclusively on a single supplier, Shree Dhootapapeshwar Limited, for all its imported products. This single-source dependency presents a potential risk, as any disruptions in the supplier's operations could directly impact Mega Medi Impex's ability to meet market demand. However, the consistent volume of shipments and the long-standing relationship with Shree Dhootapapeshwar Limited suggest a stable and reliable partnership.

2Supply Chain Resilience

Mega Medi Impex's supply chain resilience is currently limited due to its exclusive reliance on one supplier. The absence of backup suppliers and a narrow product portfolio focused solely on Ayurvedic and herbal products may expose the company to supply chain disruptions. Additionally, the company's shipping routes are primarily dependent on Indian ports, which could be affected by regional logistical challenges. Ensuring that Shree Dhootapapeshwar Limited adheres to international Good Manufacturing Practices (GMP) is crucial for maintaining product quality and regulatory compliance.

3Strategic Implications

Importing Pharmaceuticals into Nepal — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nepal

1Regulatory Authority & Framework

The Department of Drug Administration (DDA) is the primary regulatory authority overseeing the pharmaceutical sector in Nepal. Established in 1979 under the Drug Act 2035 (1978), the DDA is responsible for regulating the production, marketing, import, export, storage, supply, sale, and distribution of medicines and health technologies. The DDA enforces compliance with national and international standards to ensure the safety, efficacy, and quality of pharmaceutical products in Nepal.

2Import Licensing & GMP

To import pharmaceutical products into Nepal, companies must obtain an import license from the DDA. This process involves registering the company with the Office of Company Registrar (OCR), obtaining a Permanent Account Number (PAN) and Value Added Tax (VAT) registration, and ensuring compliance with storage requirements, including temperature-controlled facilities. Additionally, the DDA requires that imported medicines be manufactured by facilities adhering to Good Manufacturing Practices (GMP), as recognized by international standards such as WHO GMP or EU GMP. Importers must also ensure that each product is registered with the DDA before distribution. (commonlaw.com.np)

3Quality & Labeling

Mega Medi Impex Private Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Mega Medi Impex's focus on Ayurvedic and herbal products aligns with the growing consumer preference for traditional and natural remedies in Nepal. The market demand for such products is driven by cultural factors and a desire for alternative healthcare solutions. By specializing in this therapeutic area, the company caters to a specific segment of the market, differentiating itself from competitors offering conventional pharmaceutical products.

2Sourcing Profile

The company's sourcing strategy is centered on importing generic Ayurvedic and herbal formulations from India. This approach allows Mega Medi Impex to offer cost-effective products while maintaining a focus on quality. India's established reputation in the production of Ayurvedic medicines makes it a suitable partner for sourcing these products. The company's exclusive reliance on Shree Dhootapapeshwar Limited indicates a preference for long-term, stable supplier relationships.

3Market Positioning

By focusing on Ayurvedic and herbal products, Mega Medi Impex serves the segment of the Nepalese market that seeks traditional and natural healthcare solutions. This includes retail pharmacies, hospitals, and consumers interested in alternative medicine. The company's specialized product mix positions it as a key player in the niche market of Ayurvedic and herbal pharmaceuticals in Nepal.

Seller's Guide — How to Become a Supplier to Mega Medi Impex Private Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Nepalese market by partnering with Mega Medi Impex. The company's established distribution network and focus on Ayurvedic and herbal products provide a platform for suppliers to reach a targeted consumer base. Potential gaps in Mega Medi Impex's current sourcing include diversification of product offerings and the inclusion of additional suppliers to mitigate risks associated with single-source dependency.

2Requirements & Qualifications

Indian exporters seeking to supply Mega Medi Impex and the Nepalese market must ensure that their manufacturing facilities comply with international GMP standards, such as WHO GMP or EU GMP. Products must be registered with the DDA before importation, and all necessary documentation, including certificates of analysis and stability studies, must be provided. Adherence to labeling requirements in the Nepali language is also mandatory. (commonlaw.com.np)

3How to Approach

Frequently Asked Questions — Mega Medi Impex Private Limited

What products does Mega Medi Impex Private Limited import from India?

Mega Medi Impex Private Limited imports 2 pharmaceutical products across 1 categories. Top imports: Bhasma ($23.4K), Gutika ($5.3K).

Who supplies pharmaceuticals to Mega Medi Impex Private Limited from India?

Mega Medi Impex Private Limited sources from 1 verified Indian suppliers. The primary supplier is Shree Dhootapapeshwar Limited (100.0% of imports, $62.8K).

What is Mega Medi Impex Private Limited's total pharmaceutical import value?

Mega Medi Impex Private Limited's total pharmaceutical import value from India is $28.7K, based on 60 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Mega Medi Impex Private Limited focus on?

Mega Medi Impex Private Limited imports across 1 categories. The largest: Ayurvedic & Herbal Products (100.0%).

Get Full Mega Medi Impex Private Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.